Navigation Links
Encision Announces Death of Chief Executive Officer Fred F. Perner
Date:9/3/2013

es will be severely missed," said Encision's Executive Chairman, Dr. Pace.  "Fred had a vast knowledge of the medical device field, as well as friends and colleagues across the healthcare universe who were always eager to work with him. Our thoughts and prayers are with his wife and children."

Encision Inc. designs, develops, manufactures and markets innovative surgical devices that allow surgeons to optimize technique and patient safety during a broad range of surgical procedures. Based in Boulder, Colorado, the Company pioneered the development of patented AEM® Laparoscopic Instruments to improve electrosurgery and reduce the chance for patient injury in minimally invasive surgery.

In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the Company notes that statements in this press release and elsewhere that look forward in time, which include everything other than historical information, involve risks and uncertainties that may cause actual results to differ materially from those indicated by the forward-looking statements. Factors that could cause the Company's actual results to differ materially include, among others, its ability to increase net sales through the Company's distribution channels, its ability to compete successfully against other manufacturers of surgical instruments, insufficient quantity of new account conversions, insufficient cash to fund operations, delay in developing new products and receiving FDA approval for such new products and other factors discussed in the Company's filings with the Securities and Exchange Commission. Readers are encouraged to review the risk factors and other disclosures appearing in the Company's Annual Report on Form 10-K for the year ended March 31, 2013 and subsequent filings with the Securities and Exchange Commission. We do not undertake any obligation to update publicly any forward-looking statements, whether
'/>"/>

SOURCE Encision Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. From Encision Inc.: New Medicare Penalties to Include Laparoscopic Complications
2. Encision Names Patrick Pace, M.D. Chairman of the Board
3. Encision Reports First Quarter Fiscal Year 2014 Results
4. Encision to Release First Quarter 2013 Results on July 31, 2013
5. Encision Reports Fourth Quarter and Fiscal Year 2013 Results
6. Encision Inc. and Virtual Ports Ltd. Announce Exclusive Distribution Agreement for Laparoscopic Surgery Devices
7. Encision Reports 10% Product Revenue Increase in Third Quarter of Fiscal Year 2013 Results
8. Encision Reports Second Quarter of Fiscal Year 2013 Results
9. Encision Reports First Quarter of Fiscal Year 2013 Results
10. Sanomedics Announces Completion of Prime Time Medical Acquisition
11. BioLineRx Announces Issuance of United States Patent Covering Use of BL-8040 for Obtaining Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... MARLBOROUGH, Mass. , Feb. 27, 2015  Boston ... to participate in the Barclays 2015 Annual Healthcare Conference ... . Dan Brennan , executive vice ... , vice president, Investor Relations, will participate in a ... the host analyst at approximately 1:05 p.m. ET. Following ...
(Date:2/27/2015)... , Feb. 27, 2015 /CNW/ - Covalon Technologies Ltd. (the ... company, today announced financial results for its first quarter ... three months ended December 31, 2014, revenue was $1,336,685. ... was $229,820 or $0.02 per share.  ... "I am very pleased with the significant progress we ...
(Date:2/27/2015)... 2015  Uroplasty, Inc. (NASDAQ: UPI ), a ... proprietary products to treat voiding dysfunctions, today announced that ... on Tuesday, March 10, 2015. Rob Kill , ... Financial Officer, will present at 4:00 p.m. Pacific Time ... conference at the Ritz Carlton in Laguna ...
Breaking Medicine Technology:Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3Uroplasty to Participate in the 27th Annual ROTH Conference 2
... Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ... preventive vaccines against cancers and infectious diseases, announced today ... in its Phase I clinical study of VGX-3400X, a ... influenza delivered using intramuscular (IM) electroporation. These results were ...
... Vapotherm, a privately held manufacturer of respiratory care devices ... received approval from the Medical Device Bureau of Health Canada ... later this year in the Canadian hospital market. The device ... "We are pleased to receive our license in ...
Cached Medicine Technology:Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I 2Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I 3Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I 4Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I 5Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I 6Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I 7Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I 8Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I 9Vapotherm Announces Approval in Canada for New High Flow Device Designed for Heliox 2
(Date:3/1/2015)... ERISAPros is pleased to announce ... the professional staff of its Compliance Department. , Evelyn ... State University-Mortiz College of Law. Prior to joining ERISAPros, ... several Fortune 500 companies as well as several privately ... Her experiences range from benefit plan design, vendor management, ...
(Date:2/28/2015)... 28, 2015 In recent years Medical Marijuana ... practicing physicians as a way for them to expand their ... Cannabis as medicine. Since the FDA still lists Cannabis as ... available to licensed physicians that can help guide them ... Deborah Malka in Santa Cruz, CA is a leader ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 The Heart ... now a distributor of the machine. The Heart Fit ... their license, like a franchise model. The goal is ... and reverse heart disease. To buy External Counterpulsation ... Clinic can help individuals through this process and achieve ...
(Date:2/28/2015)... Fredericton, NB (PRWEB) February 28, 2015 ... call center software suite for Asterisk, are pleased to ... the highly successful 5.7 and 5.8 versions of Q-Suite, ... as well as a number of new features to ... be Q2 2015. , Q-Suite 5.9 will add features ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 ... of outsourced sales, marketing and supply chain management ... BIOTA Botanicals, is bringing its award winning solutions ... BIOTA Botanicals’ products are specifically created to combat ... experts, BIOTA is committed to marrying science with ...
Breaking Medicine News(10 mins):Health News:ERISAPros Recruits Evelyn King, J.D. and Carolyn Roddy, J.D. to its Professional Staff 2Health News:Reputable Cannabis Doctor In Santa Cruz and Monterey Joins the Medical Cannabis Network 2Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Indosoft Proudly Announces Q-Suite 5.9 Call Center Software for Asterisk 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3
... Save the Children By Charles ... WESPORT, Conn., Oct. 24 The dramatic images,of wildfires ... on,children not only in the immediate area where the ... country who are watching the,destructive power of the flames ...
... Company Becomes First to Leverage Zagat,s, Expertise to Survey ... Rate Experiences Using ... Oct. 24 WellPoint, Inc., the,nation,s largest health benefits ... of a new online survey tool that will allow,consumers ...
... Pennsylvania has reversed the medical malpractice trend, ... said that Medical Care Availability and Reduction of ... since he took office and, as,a result of ... "Pennsylvania is a success story when it ...
... a novel,medical humidifier, was awarded a prestigious R&D ... PARI Innovative Manufacturers, a leading,manufacturer of nebulizers and ... gases are heated and humidified with the aim ... greater control,of patient comfort. The award, selected ...
... -- Combat physicians in war-torn areas like Iraq and ... require massive blood transfusions (MT), and thereby increase a ... the October issue of The Journal of the American ... of a combination of three variables -- assessed immediately ...
... induced in healthy volunteers, according to a study by ... Center for Medical Cannabis Research (CMCR.) However, the ... the placebo controlled study of 15 subjects, a low ... provided moderate pain relief, and a high dose increased ...
Cached Medicine News:Health News:How to Help Children Cope With the California Wildfires 2Health News:How to Help Children Cope With the California Wildfires 3Health News:How to Help Children Cope With the California Wildfires 4Health News:WellPoint Taps Zagat Survey to Help Consumers Rate Experiences with Their Doctors 2Health News:WellPoint Taps Zagat Survey to Help Consumers Rate Experiences with Their Doctors 3Health News:Governor Rendell Says Mcare Claims and Costs Are 50 Percent Lower Than in 2003 2Health News:PARI's Hydrate Wins Prestigious R&D 100 Award 2Health News:Early predictive model may be new 'weapon' against leading cause of death on battlefield 2Health News:Smoked cannabis proven effective in treating neuropathic pain 2
... new functional test which exhibits 100% sensitivity ... Resistance caused by the Factor V Leiden ... available methods, Pefakit APC-R FVL shows no ... Anticoagulants, Elevated FVIII levels, Heparins or Prothrombin ...
Cable connections for 5 different adapters: Storz, ACMI, Pentax, Wolf and Olympus....
Lightweight PVC housing for easy transport, integrated handle. Easy lamp exchange....
... An important diagnostic tool in determining ... particularly important when deciding courses of ... immunosuppressive treatment, recurring infections and autoimmune ... for patients with autoimmune diseases giving ...
Medicine Products: